据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从202_老虎社区_美港股上老虎

据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从202

智通财经2025-08-22

据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从2025年10月逐步以片剂剂型取代胶囊剂型以满足患者的临床治疗需求并提升给药的便捷性。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2561494834?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-22 10:48","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2561494834","market":"hk","top_or_hot":-1,"title":"据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从202","media":"智通财经","content":"<div>\n<p>据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从2025年10月逐步以片剂剂型取代胶囊剂型以满足患者的临床治疗需求并提升给药的便捷性。</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从202</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从202\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-22 10:48 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=usstock><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从2025年10月逐步以片剂剂型取代胶囊剂型以满足患者的临床治疗需求并提升给药的便捷性。</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","article_id":"2561494834","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561494834","pubTimestamp":1755830894,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从2025年10月逐步以片剂剂型取代胶囊剂型以满足患者的临床治疗需求并提升给药的便捷性。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688235":"百济神州","BK1583":"高瓴概念","BK0239":"医药制造","06160":"百济神州","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK1500":"做空集合股","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","ONC":"百济神州","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK4201":"综合性石油与天然气企业","EC":"哥伦比亚国家石油","BK1588":"回港中概股","BK1161":"生物科技","BK4526":"热门中概股","BK4585":"ETF&股票定投概念","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK4139":"生物科技"},"translate_title":"According to BeiGene, the European Commission (EC) has approved the new film-coated tablet dosage form of Baiyueze (Zebutinib) for all locally approved indications. The EU market will increase from 202","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688235":1,"ONC":1,"EC":1,"06160":1,"FESXmain":1,"FSXEmain":1},"content_text":"据百济神州消息欧盟委员会（EC）已批准百悦泽（泽布替尼）新的薄膜包衣片剂剂型用于所有当地已获批适应症。欧盟市场将从2025年10月逐步以片剂剂型取代胶囊剂型以满足患者的临床治疗需求并提升给药的便捷性。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}